Capivasertib in Advanced Breast Cancer | NEJM
20
0
2023-11-15 17:02
Inherited Breast Cancer Genes and Ancestry - Progress and Pitfalls
Interrupting Therapy to Attempt Pregnancy after Breast Cancer | NEJM
6 cancer symptoms women shouldn't ignore
RCOG GUIDELINE PREGNANCY AND BREAST CANCER Part 1
RCOG GUIDELINE PREGNANCY AND BREAST CANCER Part 2
Breast Cancer Overdiagnosis May Not Happen as Frequently as Previously Thought
肿瘤病理基础训练营DAY4 乳腺癌病理报告ER,PR及HER2解读
临床-病理-影像联合模型构建列线图预测乳腺癌新辅助治疗pCR
0 bullet chats
Please Sign In first
LikesSend-PenFavorites
Scan by WeChatUnauthorized reproduction is prohibited
Appropriate endocrine therapy is unclear for hormone receptor–positive, HER2-negative advanced breast cancer that progresses despite treatment with an aromatase inhibitor with or without a CDK4/6 inhibitor.
New research findings are summarized in this short video.
To see the full article, follow this link: https://nej.md/3qc9C0h
Comments 0
Please to post a comment~
Loading...
Related Suggestion